Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 9 | -$1.12 | -$0.87 | -$0.99 |
| Q2 2026 | 9 | -$1.17 | -$0.93 | -$1.07 |
| Q3 2026 | 10 | -$1.31 | -$0.81 | -$1.11 |
| Q4 2026 | 4 | -$1.97 | -$0.17 | -$1.07 |
| Q1 2027 | 4 | -$2.04 | -$0.18 | -$1.11 |
| Q2 2027 | 4 | -$1.99 | -$0.17 | -$1.08 |
| Q3 2027 | 4 | -$1.65 | -$0.14 | -$0.89 |
| Q4 2027 | 4 | -$1.70 | -$0.15 | -$0.92 |
Ideaya Biosciences Inc last posted its earnings results on Tuesday, May 5th, 2026. The company reported $-1.11 earnings per share for the quarter, missing analysts' consensus estimates of $-1.07 by $0.04. The company had revenue of 6.56 M for the quarter and had revenue of 218.71 M for the year. Ideaya Biosciences Inc has generated $-1 earnings per share over the last year ($-1.28 diluted earnings per share) and currently has a price-to-earnings ratio of -18.3. Ideaya Biosciences Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/05/2026 | Q1 2026 | -$1.07 | -$1.11 | -0.04 | $5.04 M | $6.56 M |
| 02/17/2026 | Q4 2025 | -$0.95 | -$0.94 | 0.01 | $6.31 M | $10.88 M |
| 11/04/2025 | Q3 2025 | -$0.95 | $1.35 | 2.3 | $6.34 M | $207.83 M |
| 08/05/2025 | Q2 2025 | -$0.85 | -$0.88 | -0.03 | $4.19 M | $0 |
| 05/06/2025 | Q1 2025 | -$0.75 | -$0.82 | -0.07 | $2.15 M | $0 |
| 02/18/2025 | Q4 2024 | N/A | -$1.49 | N/A | $5.09 M | $7.00 M |
| 11/04/2024 | Q3 2024 | -$0.67 | -$0.60 | 0.07 | $4.27 M | $0 |
| 08/06/2024 | Q2 2024 | -$0.55 | -$0.68 | -0.13 | $4.46 M | $0 |
| 08/06/2024 | Q1 2024 | -$0.55 | -$0.53 | 0.02 | $5.43 M | $0 |
| 02/20/2024 | Q4 2023 | -$0.49 | -$0.52 | -0.03 | N/A | $3.92 M |
| 11/07/2023 | Q3 2023 | -$0.47 | -$0.46 | 0.01 | N/A | $8.04 M |
| 08/10/2023 | Q2 2023 | -$0.53 | -$0.50 | 0.03 | N/A | $3.54 M |
| 05/09/2023 | Q1 2023 | -$0.51 | -$0.41 | 0.1 | N/A | $7.88 M |
| 03/07/2023 | Q4 2022 | -$0.57 | -$0.46 | 0.11 | N/A | $4.02 M |
| 11/08/2022 | Q3 2022 | -$0.65 | $0.06 | 0.71 | N/A | $29.70 M |
| 08/15/2022 | Q2 2022 | -$0.57 | -$0.56 | 0.01 | N/A | $5.85 M |
| 05/10/2022 | Q1 2022 | -$0.41 | -$0.47 | -0.06 | N/A | $11.36 M |
| 03/17/2022 | Q4 2021 | N/A | -$0.47 | N/A | N/A | $2.96 M |
| 11/15/2021 | Q3 2021 | -$0.29 | -$0.31 | -0.02 | N/A | $8.98 M |
| 08/10/2021 | Q2 2021 | -$0.07 | -$0.33 | -0.26 | N/A | $8.76 M |
The conference call for Ideaya Biosciences Inc's latest earnings report can be listened to online.
The conference call transcript for Ideaya Biosciences Inc's latest earnings report can be read online.
Ideaya Biosciences Inc (:IDYA) has a recorded annual revenue of $218.71 M.
Ideaya Biosciences Inc (:IDYA) has a recorded net income of $-113,698,000.Ideaya Biosciences Inc has generated $-1.28 earnings per share over the last four quarters.
Ideaya Biosciences Inc (:IDYA) has a price-to-earnings ratio of -18.3 and price/earnings-to-growth ratio is -0.42.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED